Tekla Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,053	Closed	-$236K	–	178
2021 Q2	$236K	Hold	7,053	–	–	0.01%	185
2021 Q1	$145K	Hold	7,053	–	–	0.01%	193
2020 Q4	$124K	Hold	7,053	–	–	﹤0.01%	198
2020 Q3	$105K	Hold	7,053	–	–	﹤0.01%	201
2020 Q2	$92K	Hold	7,053	–	–	﹤0.01%	220
2020 Q1	$12K	Hold	7,053	–	–	﹤0.01%	216
2019 Q4	$16K	Hold	7,053	–	–	﹤0.01%	214
2019 Q3	$15K	Hold	7,053	–	–	﹤0.01%	192
2019 Q2	$19K	Hold	7,053	–	–	﹤0.01%	197
2019 Q1	$35K	Hold	7,053	–	–	﹤0.01%	193
2018 Q4	$21K	Hold	7,053	–	–	﹤0.01%	203
2018 Q3	$48K	Hold	7,053	–	–	﹤0.01%	211
2018 Q2	$53K	Hold	7,053	–	–	﹤0.01%	180
2018 Q1	$247K	Hold	7,053	–	–	0.01%	183
2017 Q4	$300K	Hold	7,053	–	–	0.01%	158
2017 Q3	$303K	Hold	7,053	–	–	0.01%	149
2017 Q2	$261K	Hold	7,053	–	–	0.01%	141
2017 Q1	$382K	Hold	7,053	–	–	0.01%	135
2016 Q4	$375K	Hold	7,053	–	–	0.02%	139
2016 Q3	$427K	Hold	7,053	–	–	0.02%	139
2016 Q2	$464K	Hold	7,053	–	–	0.02%	137
2016 Q1	$400K	Hold	7,053	–	–	0.02%	136
2015 Q4	$1.66M	Sell	7,053 -15,507	-69%	-$3.65M	0.06%	124
2015 Q3	$3.57M	Buy	+22,560	New	+$3.57M	0.13%	101
2014 Q4	–	Sell	-33,893	Closed	-$6.59M	–	95
2014 Q3	$6.59M	Buy	+33,893	New	+$6.59M	0.31%	65